AFFF Lawsuit 2025 | Firefighting Foam Cancer Claims & Settlement Updates

The AFFF Lawsuit 2025 centers on claims that firefighting foam containing PFAS chemicals caused serious health problems, including multiple forms of cancer, among firefighters, military personnel, and nearby residents. These toxic “forever chemicals” have been found to contaminate water supplies and accumulate in the human body, leading to long-term health risks. As the litigation progresses, major chemical manufacturers and government agencies face growing legal pressure over their role in producing and distributing these hazardous foams. In this page, we cover the latest firefighting foam cancer claims, court developments, and settlement updates shaping the AFFF lawsuit in 2025.

What Is the AFFF Firefighting Foam Lawsuit About?

The AFFF firefighting foam lawsuit is a major legal action involving claims that aqueous film-forming foam (AFFF), used for decades to extinguish fuel fires, contains toxic chemicals known as PFAS or “forever chemicals.” These substances have been linked to serious health conditions, including various cancers, liver and thyroid diseases, and immune system damage.

Firefighters, military personnel, airport workers, and nearby residents allege that manufacturers like 3M, DuPont, and others knew about the health and environmental risks of PFAS but failed to warn users. The lawsuit seeks compensation for medical costs, pain and suffering, and long-term contamination cleanup.

Timeline of AFFF Firefighting Foam Litigation

The Aqueous Film-Forming Foam (AFFF) lawsuits have developed into one of the largest and most complex multidistrict litigations in U.S. history. These cases involve firefighters, military personnel, and communities exposed to toxic PFAS chemicals in firefighting foam. Over the years, key court rulings, scientific studies, and major settlements have shaped the path toward accountability. The timeline below highlights the most important developments that have defined the progress of the AFFF litigation.

September 15, 2025 – Focus Shifts to Kidney and Testicular Cancer Lawsuits

The litigation is now placing greater emphasis on testicular and kidney cancer claims, signaling a strategic prioritization of these cancer types in the next stages of the AFFF proceedings.

September 2, 2025 – Massive Influx of New AFFF Claims Filed Before Deadline

A record-breaking 37,446 new AFFF lawsuits were filed last week, far surpassing expectations. This unprecedented wave was driven by the deadline under Judge Gergel’s Case Management Order No. 35, revealing the vast scale of unfiled claims known to exist within the litigation.

September 1, 2025 – Veterans Still Waiting for PFAS Accountability

Many of the AFFF and PFAS plaintiffs are veterans or members of military families. Years of foam use have contaminated hundreds of bases, yet there is still no national registry to document exposure or related illnesses. As a result, affected service members must repeatedly prove that their cancers or thyroid conditions are tied to their time on polluted bases. The EPA’s near-zero limits for PFAS in drinking water reveal how toxic these substances are, but without a formal registry, veterans receive little more than assurances instead of real medical monitoring or timely diagnoses. The absence of government action makes these lawsuits even more essential. For many veterans, litigation remains the only path to accountability, recognition, and justice.

August 17, 2025 – Filing Window Opens After PFAS Trial Delay

The first bellwether personal injury trial in the PFAS foam MDL has been delayed due to a major backlog of unfiled cases. In Case Management Order No. 35, Judge Richard Gergel introduced a 21-day “Filing Facilitation Window” lasting through September 5, 2025. During this period, the Plaintiffs’ Executive Committee must file all personal injury claims involving the six core health conditions—kidney cancer, testicular cancer, ulcerative colitis, thyroid disease, liver cancer, and thyroid cancer. Other attorneys are urged to file as well. To streamline the process, the court is allowing consolidated complaints of up to 150 plaintiffs and short-form filings, each supported by diagnosis proof, water exposure evidence, and residence history submitted through the EAG portal. Judge Gergel emphasized that the sudden influx of unfiled cases could strain MDL management and stall settlements. Both sides must submit progress reports within 30 and 60 days. This September 5 deadline may effectively act as a cutoff for claim eligibility, making prompt action critical for those seeking compensation for PFAS-related harm.

August 15, 2025 – Study Links PFAS Exposure to Gene-Regulating MicroRNA Changes

A new study published in Environmental Research examined blood samples from more than 300 U.S. firefighters and found strong evidence connecting PFAS exposure to disruptions in microRNAs, the molecules that regulate gene activity. Researchers focused on PFAS compounds from firefighting foam, especially linear and branched PFOS, and discovered that exposure led to reduced levels of key microRNAs like miR-128-1-5p and members of the let-7 family—both crucial for tumor suppression and immune function. Mapping these molecular shifts revealed associations with multiple diseases, including leukemia, kidney, bladder, and liver cancers, along with Alzheimer’s, lupus, and rheumatoid arthritis. Some PFAS even triggered disease-linked gene patterns without directly affecting microRNAs, suggesting broader biological harm. For AFFF-exposed individuals, this study underscores that PFAS do more than linger—they interfere with the body’s protective systems, reinforcing the urgent need for accountability and health monitoring.

August 5, 2025 – New AFFF Lawsuit Filed by Illinois Firefighter with Kidney Cancer

A former firefighter from Arcola, Illinois, has filed a new lawsuit joining the AFFF multidistrict litigation, claiming that PFAS exposure from firefighting foam caused his kidney cancer. The plaintiff served in both military and civilian firefighting roles, frequently handling AFFF during training and emergency operations. He also lived and worked in Wisconsin, where the local water supply was allegedly contaminated with PFAS. The complaint names several corporate defendants responsible for producing and distributing AFFF and its chemical components, asserting they knew or should have known about the severe health and environmental dangers of PFAS.

July 28, 2025 – Extension Granted for Selecting New Tier 2 Group B Plaintiffs

Judge Richard Gergel has approved a joint request from both parties for additional time, extending the deadline to August 4, 2025, to finalize how new discovery pool plaintiffs will be chosen for Tier 2 Group B cases under Case Management Order 26H. The extension allows more room for negotiation on which cases will move forward for detailed discovery. Previously, the Court had identified three Tier 2 Group B cases, two involving ulcerative colitis and one involving thyroid disease, and directed both sides to propose a selection plan by June 27, 2025. That timeline was pushed back, and discovery for these cases is now set to close on September 12, 2025, unless further extended.

July 24, 2025 – Treating Physicians Play a Crucial Role in AFFF Trials

In large-scale litigation like class actions and MDLs, establishing general causation is essential to move past summary judgment. But once the case reaches trial, juries respond more strongly to authenticity than to complex science. That is why treating physicians often become key witnesses. Unlike paid experts, they are firsthand observers who treated plaintiffs directly, giving their testimony credibility and emotional weight. When a treating doctor describes a patient’s symptoms, test results, and daily challenges, jurors see the case in human terms rather than scientific abstractions. A strong trial strategy means letting expert witnesses establish the medical connection, while allowing treating doctors to bring the plaintiff’s suffering to life in a way the jury can truly connect with.

July 23, 2025 – Proposed Bill Seeks Compensation for Firefighters Exposed to PFAS

The Firefighter PFAS Injury Compensation Act of 2024, introduced by Senator Cory Booker with bipartisan support, aims to provide medical and financial benefits to firefighters exposed to toxic PFAS chemicals found in firefighting foam. These chemicals have been associated with serious health issues central to ongoing AFFF litigation. The bill proposes a federal compensation program covering two categories of PFAS-related illnesses: Category A includes kidney, testicular, liver, and thyroid cancers, qualifying thyroid diseases, and ulcerative colitis, while Category B includes prostate, breast, pancreatic, and bladder cancers. This legislation would create an independent compensation path separate from the lawsuits. However, its passage remains uncertain, as new federal spending measures often face delays due to political and budgetary challenges.

July 22, 2025 – Court Holds Emergency Meeting Over Surge in Unfiled AFFF Claims

Judge Richard Gergel convened an emergency teleconference to address a sudden influx of unfiled personal injury claims in the AFFF multidistrict litigation. Reports indicate that tens of thousands of potential cases have surfaced, creating concern about disruptions to settlement discussions ahead of the first bellwether trial set for October. The judge ordered plaintiffs’ counsel to provide detailed figures on both filed and unfiled cases and to identify firms managing over 100 unfiled claims. Defense attorneys argued that the surge could hinder case management and complicate the bellwether process, prompting court involvement. Although plaintiffs accused the defense of violating mediation confidentiality, Judge Gergel determined that the court was entitled to be kept informed.

July 21, 2025 – Firefighters File Nationwide PFAS Exposure Lawsuit in Illinois

Firefighters from across the United States have filed a lawsuit in Madison County, Illinois, alleging severe health problems caused by long-term exposure to PFAS chemicals found in firefighting foam and protective gear. The plaintiffs, both military and civilian firefighters, accuse more than 50 manufacturers, including 3M, DuPont, and Chemours, of knowingly producing and selling PFAS-laced products despite decades of evidence showing serious health risks such as cancer and thyroid disease. The lawsuit claims the companies ignored internal research and regulatory warnings while continuing to market these products. The plaintiffs, many diagnosed with kidney, thyroid, and testicular cancers or ulcerative colitis, assert they used the products as intended and were never warned of the dangers. Defendants are now seeking to transfer the case to the AFFF multidistrict litigation for consolidation.

July 18, 2025 – Tension Rises Over Unfiled AFFF Claims Before Mediation

A conflict has erupted in the AFFF multidistrict litigation after defense attorneys requested a court meeting to address the rapidly growing number of unfiled personal injury claims, now estimated in the tens of thousands. The defense argued that the influx could disrupt scheduling, mediation, and the bellwether process, urging judicial intervention ahead of the July 25 mediation session. Plaintiffs’ lawyers fired back, accusing the defense of violating the Mediation Agreement and Federal Rule of Evidence 408 by disclosing confidential mediation data for strategic gain. They criticized the defense for acting without mediator involvement and giving little notice, calling the move a breach of nearly three years of cooperative negotiations. While the number of unfiled cases has long been an open secret, this dispute has intensified tensions as the litigation edges closer to trial.

July 1, 2025 – Judge Urges Swift Settlements Before AFFF Bellwether Trial

During the latest status conference, Judge Richard Gergel pressed both sides in the AFFF multidistrict litigation to reach personal injury settlements before the first bellwether trial begins in October. The initial trial will center on kidney cancer claims, with thyroid and other illnesses to follow. Over 10,000 lawsuits remain pending, covering personal injury, property damage, and PFAS contamination. The judge’s message was clear: defendants including 3M, DuPont, BASF, and Johnson Controls should settle soon rather than risk trial verdicts. Prior settlements with public water systems have already topped $13 billion, creating mounting pressure to resolve personal injury claims. Legal experts anticipate a large-scale settlement this summer as defendants weigh the growing financial risks of continuing litigation.

June 17, 2025 – Judge Gergel Sets Schedule for First AFFF Bellwether Trial

Judge Gergel issued a scheduling order setting the roadmap for the first personal injury bellwether trial in the AFFF litigation, focused on kidney cancer claims linked to firefighting foam exposure. The court has yet to decide which of the three plaintiffs (Donnelly, Speers, or Voelker) will go first, but the deadlines now in place show the MDL is shifting from pretrial activity to full trial preparation. The trial is slated to begin on October 20, 2025, with key filings, exhibit exchanges, and witness disclosures taking place in the months leading up to it. Judge Gergel’s order outlines strict requirements for juror questionnaires, exhibit lists, deposition designations, and demonstrative evidence to ensure efficiency and fairness. The clear message is that delays are over and the litigation is moving toward its first trial or a potential global AFFF settlement.

June 3, 2025 – New Study Strengthens Firefighters’ AFFF Exposure Claims

A peer-reviewed study published in 2025, titled “Differences in serum concentrations of per-and polyfluoroalkyl substances by occupation among firefighters, other first responders, healthcare workers, and other essential workers in Arizona, 2020–2023,” has added strong scientific backing to the AFFF lawsuits. Conducted on nearly 2,000 frontline workers, the study found that firefighters had significantly higher blood concentrations of PFAS chemicals such as PFHxS, PFOS, and PFHpS compared to other essential workers, even after controlling for demographic factors. The findings demonstrate a clear occupational link between firefighting foam use and PFAS accumulation, reinforcing plaintiffs’ arguments about exposure and causation. The data show PFAS contamination from AFFF is measurable, occupation-specific, and supported by solid epidemiological evidence, strengthening the case against manufacturers accused of failing to warn users about the risks.

April 26, 2025 – Ulcerative Colitis Cases Gain Momentum in AFFF MDL

The MDL judge released Case Management Order 26H to revise the schedule for Group B bellwether cases focused on ulcerative colitis. Three additional plaintiffs were added to the discovery pool, with Tier 1 discovery running from April 7 to August 11, 2025. By July 21, both parties must suggest which new plaintiffs should advance to Tier 2, with the expectation that at least one will be chosen. Ongoing Tier 2 discovery for existing plaintiffs is set to close by September 12, 2025, and progress updates are due at the August 8 status conference. The order signals that ulcerative colitis claims are moving steadily toward potential trial readiness and could serve as leverage for future settlements, reflecting the judge’s intent to maintain pressure on both sides to resolve these cases efficiently.

January 28, 2025 – Punitive Damages May Drive AFFF Settlement Push

Punitive damages are emerging as a major factor that could accelerate AFFF settlement talks before the first personal injury trial begins this year. These damages aim to punish companies for intentional or reckless misconduct. Plaintiffs argue that 3M, DuPont, and other manufacturers knowingly hid the dangers of PFAS-laden firefighting foam for decades, prioritizing profits over safety. Internal records show awareness of health risks as early as the 1960s without any warnings to users. This level of corporate negligence could motivate juries to award substantial punitive damages, creating immense financial pressure on defendants to settle. As a result, plaintiffs in the AFFF litigation may see higher settlement values that reflect both their injuries and the gravity of the defendants’ actions.

October 23, 2024 – Texas Navy Veteran Files AFFF Lawsuit Over Thyroid Cancer

A plaintiff from Boerne, Texas, has filed a new claim in the AFFF multidistrict litigation, alleging that years of exposure to PFAS-based firefighting foam during U.S. Navy service caused thyroid cancer and other health problems. The lawsuit targets several manufacturers, including 3M, Chemours, and DuPont, accusing them of producing and distributing AFFF products with dangerous PFAS compounds that are carcinogenic and bioaccumulative.

June 27, 2024 – Study Confirms PFAS Skin Absorption Risks in Firefighting Foam Exposure

A new peer-reviewed study has provided key insights into how PFAS chemicals penetrate human skin using 3D human skin models. It found that shorter-chain PFAS absorb more easily, while longer-chain variants tend to remain stored within skin tissue, potentially entering the body over time. This research reinforces plaintiffs’ claims in AFFF lawsuits by demonstrating that dermal exposure is a significant route of PFAS absorption, supporting arguments that manufacturers like 3M should have warned users about the dangers of skin contact with these chemicals.

March 6, 2024 – Court Issues New Procedures for Firefighter Turnout Gear PFAS Claims

As PFAS-related claims involving firefighter turnout gear gain attention, a new Case Management Order No. 5F has been issued to streamline how these cases proceed. Firefighters allege that PFAS chemicals used in protective gear have caused illnesses such as cancer, thyroid disease, and liver damage. The court’s order introduces a specific Plaintiff Fact Sheet (PFS) requirement for these claims, ensuring that each case provides detailed information about the firefighter’s exposure, health conditions, and use of PFAS-laden gear.

October 5, 2023 – Study Strengthens Link Between AFFF Exposure and Testicular Cancer

A recently published study provides the strongest evidence yet connecting AFFF exposure to testicular cancer. While earlier research already indicated this association, this new data adds compelling scientific confirmation, reinforcing existing claims within the AFFF litigation over the severe health effects of PFAS chemicals.

August 20, 2023 – Research Confirms Elevated Testicular Cancer Risk From AFFF Use

Fresh scientific findings have confirmed that exposure to firefighting foam containing PFAS can significantly increase the risk of testicular cancer. The study’s results align with what attorneys and affected individuals have long suspected, bolstering ongoing AFFF lawsuits.

August 18, 2023 – Air Force Veteran Files AFFF Lawsuit Over Prostate Cancer

A 73-year-old retired firefighter from Texas has filed an AFFF lawsuit in South Carolina federal court, claiming exposure to fluorochemical firefighting products during his Air Force service caused prostate cancer. The plaintiff underwent a prostatectomy and seeks damages for his suffering, naming 3M and other chemical manufacturers as defendants responsible for his illness.

August 1, 2023 – Plaintiff’s Death Leads to Substitution in AFFF Wrongful Death Lawsuit

Judge Gergel approved an unopposed motion to substitute plaintiffs after an Alabama man involved in the AFFF litigation passed away. His daughter is now the plaintiff in the wrongful death case. This highlights the harsh reality that some plaintiffs may not live to see their settlements finalized.

June 2, 2023 – DuPont, Chemours, and Corteva Announce $1.185 Billion PFAS Water Settlement

The Chemours Company, DuPont de Nemours, and Corteva have reached a preliminary agreement to resolve PFAS-related drinking water claims. The companies will create a $1.185 billion settlement fund to compensate affected public water systems, pending final approval by the U.S. District Court for the District of South Carolina. Certain water systems are excluded from the deal.

February 3, 2023 – Statute of Limitations Does Not Always Bar AFFF Lawsuits

Many victims of PFAS exposure assume they cannot file claims due to expired statutes of limitations, but the discovery rule often extends these deadlines. Courts have allowed cases to proceed when plaintiffs only recently learned of their injuries’ connection to AFFF. Some states also have special rules for toxic exposure or concealment, giving survivors more time to seek justice. Anyone diagnosed with PFAS-linked conditions such as kidney, testicular, or thyroid cancer should seek a legal review rather than assume they are out of time.

January 12, 2023 – Study Finds Firefighters Face 60% Higher Cancer Death Risk

A new Occupational Medicine study found that firefighters are 60% more likely to die from cancer than the general population. The rate of prostate cancer deaths was four times higher, leukemia three times higher, and kidney cancer doubled. Researchers identified carcinogenic exposure from AFFF as a major contributing factor.

November 1, 2022 – Mediator Appointed to Advance AFFF Settlement Talks

Ahead of the first bellwether trial in 2024, retired judge Layn Phillips has been appointed as mediator to lead settlement discussions in the AFFF multidistrict litigation. The talks aim to address both individual firefighter cancer claims and municipal water contamination suits. Water contamination cases are expected to settle first since they are scheduled for trial sooner.

Health Risks & Injuries Linked to AFFF Exposure

Exposure to AFFF firefighting foam has been linked to serious health risks because it contains toxic PFAS chemicals that accumulate in the body over time. These “forever chemicals” do not break down easily, leading to long-term contamination of blood, soil, and water.

Studies have connected AFFF exposure to several types of cancer, including kidney, testicular, pancreatic, and bladder cancer. Other reported health issues include thyroid disorders, liver damage, immune system dysfunction, fertility problems, and developmental effects in children.

Firefighters and military personnel face the highest risk due to repeated exposure, while nearby residents may suffer harm from contaminated groundwater or soil.

Who Can Join the AFFF Firefighting Foam Lawsuit?

Anyone who has been exposed to AFFF firefighting foam and later developed related health issues, especially cancer, may be eligible to join the AFFF lawsuit. This includes firefighters, military personnel, airport workers, chemical plant employees, and people living near military bases or training sites where AFFF was regularly used.

To qualify, plaintiffs usually need to show that they were exposed to AFFF for a long time and were later diagnosed with a condition linked to PFAS exposure such as kidney, testicular, or pancreatic cancer. Family members of deceased victims may also file wrongful death claims.

Settlement Status and Compensation Outlook in the AFFF Firefighting Foam Lawsuit

The AFFF lawsuit is accelerating in 2025, with thousands of new claims filed and both individual injury and water-contamination cases advancing through the federal MDL. A global resolution is widely expected, though no definitive settlement has been announced yet.

Settlement estimates vary significantly. Claimants with severe cancers linked to AFFF exposure and extensive occupational contact may qualify for payouts ranging from $300,000 to $600,000. Cases with less exposure or milder illnesses are estimated in the $150,000 to $280,000 range, while minimal exposure claims may settle for $75,000 or less.

Actual compensation will depend on exposure level, diagnosis severity, and the strength of evidence tying AFFF to the injury.

Legal Strategies, Court Decisions & What They Mean for the AFFF Firefighting Foam Lawsuit

The AFFF lawsuit has seen major developments as courts refine how liability and causation are addressed. Plaintiffs’ legal strategies focus on proving that chemical manufacturers knowingly produced and sold firefighting foams containing toxic PFAS chemicals, despite being aware of their long-term environmental and health dangers.

Defendants, including 3M, DuPont, and others, argue that AFFF use was mandated by military and government safety standards, reducing their liability. Recent court rulings have both supported and challenged these defenses, shaping how future claims will proceed.

Notably, several judges have upheld scientific evidence linking PFAS exposure to cancers and immune system damage, allowing plaintiffs’ expert testimonies to stand. These rulings strengthen the position of victims and may pressure manufacturers to negotiate broader settlements.

Overall, court decisions in 2025 indicate growing judicial recognition of PFAS-related harm, setting the stage for more consistent compensation frameworks and accountability across jurisdictions.

What Comes Next in the AFFF Firefighting Foam Lawsuit

The AFFF lawsuit is entering a critical phase as courts prepare for more trials and potential nationwide settlements. Several bellwether cases have already been decided or are pending, and upcoming verdicts will help shape compensation amounts and clarify liability for the remaining claims.

With growing evidence linking PFAS exposure to serious health conditions, more firefighters, military members, and airport workers are expected to join the litigation. The multidistrict litigation court will continue managing thousands of cases to promote faster resolutions and settlement discussions.

Manufacturers could face mounting pressure to reach broader settlement agreements as legal rulings and scientific data increasingly support plaintiffs. In the months ahead, much attention will focus on how these cases progress and whether new claims will continue to emerge as awareness of AFFF-related risks expands.

Frequently Asked Questions on the AFFF Lawsuit 2025